Milestone Pharmaceuticals Inc. - Common Shares - balanço patrimonial (NASDAQ:MIST) | MetaTrader

Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas

Total de ativos 149.97 M119.85 M74.48 M75.23 M75.5 M113.56 M Total de passivos 6.86 M7.25 M8.13 M58.45 M62.35 M71.79 M Capital total 143.12 M112.6 M66.35 M16.77 M13.15 M41.77 M Total de passivos e patrimônio líquido 149.97 M119.85 M74.48 M75.23 M75.5 M113.56 M Dívida total —————— Dívida líquida ——————

Notícias

Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript

Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales - Milestone Pharmaceuticals (NASDAQ:MIST

Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates

Lucro da Milestone Pharmaceuticals veio abaixo das projeções por $0,43; receita menor do que estimativas

Ações da Milestone Pharmaceuticals caem 16% após receita abaixo do esperado

Milestone Pharmaceuticals planeja estudo de registro de TPSV no mundo real

Raymond James inicia cobertura da Milestone Pharmaceuticals com recomendação de compra forte

Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call Transcript

Milestone Pharmaceuticals atinge previsão de LPA, mas ação cai

Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Milestone Pharmaceuticals (NASDAQ:MIST)

Milestone Stock: Downgrading To Sell As CARDAMYST Faces A Tough Reality (NASDAQ:MIST)

Milestone Pharmaceuticals appoints David Sandoval as general counsel